NASDAQ:ARWR
Arrowhead Pharmaceuticals, Inc.
- Stock
Last Close
24.08
30/08 20:00
Market Cap
3.33B
Beta: 1.01
Volume Today
1.17M
Avg: 1.11M
PE Ratio
−16.68
PFCF: −12.05
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '13 | Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -31.14M - | -58.63M 88.26% | -91.94M 56.81% | -81.72M 11.11% | -34.38M 57.93% | -54.45M 58.38% | 67.97M 224.84% | -84.55M 224.39% | -140.85M 66.58% | -176.49M 25.31% | -209.28M 18.57% | |
depreciation and amortization | 1.75M - | 1.35M 23.17% | 2.34M 73.61% | 3.26M 39.54% | 4.69M 43.88% | 4.70M 0.19% | 4.44M 5.54% | 5.94M 33.86% | 8.27M 39.12% | 10.42M 26.06% | 12.49M 19.88% | |
deferred income tax | 7.69M - | 8.09M 5.21% | -2.89M 135.69% | 2.35M 181.42% | -890.36K 137.86% | -432.14K 51.46% | -34.41M - | |||||
stock based compensation | 1.54M - | 5.70M 270.78% | 10.23M 79.65% | 11.60M 13.32% | 7.89M 31.94% | 8.45M 7.13% | 12.39M 46.59% | 43.38M 250.05% | 76.67M 76.74% | 120.89M 57.67% | 78.13M 35.37% | |
change in working capital | 140.01K - | 5.00M 3,474.40% | 3.41M 31.91% | 5.72M 67.80% | -1.21M 121.10% | -5.88M 387.04% | 87.16M 1,582.85% | -60.69M 169.63% | 226.87M 473.82% | -98.29M 143.33% | -51.55M 47.56% | |
accounts receivables | -65.63K - | 75K 214.29% | -75K - | 7.20K 109.60% | -259.58K 3,703.75% | -333.99K 28.66% | -184.31K 44.81% | -9.41M 5,004.93% | 8.85M 194.01% | 1.41M 84.06% | ||
inventory | -20.23M - | -139.44M 589.10% | -1.89M - | 2.41M 227.48% | 1.34M 44.64% | -1.26M 194.37% | 1.60M 227.10% | 9.16M 471.90% | -3.36M - | |||
accounts payables | 321.65K - | 1.41M 339.08% | 2.50M 76.86% | 2.55M 2.28% | -3.51M 237.39% | -1.27M 63.81% | 4.84M 481.28% | -821.01K 116.95% | 2.63M 420.09% | -6.59M 350.72% | 33.00M 600.80% | |
other working capital | 20.12M - | 142.95M 610.55% | 909.98K 99.36% | 5.13M 463.88% | -116.77K 102.28% | -5.68M 4,767.16% | 83.91M 1,576.38% | -61.29M 173.04% | 224.49M 466.29% | -100.55M 144.79% | -82.59M 17.86% | |
other non cash items | 990.27K - | 3.07M 210.45% | 13.14M 327.57% | -5.63M 142.83% | -43.52K 99.23% | 383.07K 980.25% | 1.07M 179.08% | 525.30K 50.86% | 266K 49.36% | 7.34M 2,660.15% | 50.72M 590.78% | |
net cash provided by operating activities | -19.03M - | -35.42M 86.08% | -65.71M 85.53% | -64.43M 1.95% | -23.94M 62.84% | -47.22M 97.27% | 173.03M 466.42% | -95.39M 155.13% | 171.22M 279.50% | -136.13M 179.50% | -153.89M 13.05% | |
investments in property plant and equipment | -296.88K - | -1.72M 478.47% | -1.97M 14.75% | -3.86M 95.89% | -7.92M 105.12% | -1.42M 82.05% | -12.00M 744.41% | -11.95M 0.41% | -23.57M 97.19% | -52.78M 123.94% | -176.74M 234.88% | |
acquisitions net | -10M - | 7.43B - | 47.75B 542.18% | 240.78B 404.29% | 141.68M 99.94% | -47.36M 133.43% | ||||||
purchases of investments | -10.73M - | -46.37M 332.01% | -44.97M - | -52.08M 15.81% | -90.27M 73.31% | -278.96M 209.05% | -240.70M 13.72% | -223.39M 7.19% | -246.14M 10.18% | |||
sales maturities of investments | 1.42M - | 11.59M 716.81% | 26.09M 125.09% | 17.31M 33.66% | 4.25M 75.45% | 46.07M 984.31% | 54.52M 18.35% | 50.14M 8.04% | 122.59M 144.51% | 270.75M 120.86% | 326.72M 20.67% | |
other investing activites | 89.50K - | 10K 88.83% | 500 95% | -7.43B - | -47.75B 542.18% | -240.78B 404.29% | -141.68M 99.94% | 47.36M 133.43% | ||||
net cash used for investing activites | -9.52M - | -36.48M 283.18% | 14.12M 138.71% | 13.45M 4.77% | -48.64M 461.73% | -7.43M 84.72% | -47.75M 542.18% | -240.78M 404.29% | -141.68M 41.16% | -5.42M 96.18% | -96.16M 1,675.06% | |
debt repayment | -214.80K - | -225.41K 4.94% | -213.99K 5.06% | -217.55K 1.66% | -197.79K 9.08% | -208.51K 5.42% | -2.42M 1,058.31% | -250M - | ||||
common stock issued | 44.51M - | 172.64M 287.91% | 52.23M - | 12.42M 76.22% | 56.59M 355.63% | 60.52M 6.96% | 250.48M 313.87% | 11.30M 95.49% | 5.19M 54.13% | 3.05M 41.13% | ||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 12.88M - | 504.51K 96.08% | 3.12M 518.01% | -166.02K 105.32% | 3.58M 2,254.26% | 8.28M 131.38% | 7.47M 9.75% | 60M - | 500M 733.33% | |||
net cash used provided by financing activities | 44.29M - | 185.29M 318.35% | 290.52K 99.84% | 55.13M 18,876.88% | 12.06M 78.13% | 59.95M 397.32% | 66.38M 10.72% | 257.95M 288.58% | 11.30M 95.62% | 65.19M 476.61% | 253.05M 288.20% | |
effect of forex changes on cash | 410K - | -88K 121.46% | -67K 23.86% | -122K 82.09% | ||||||||
net change in cash | 15.74M - | 113.40M 620.56% | -51.30M 145.24% | 4.15M 108.09% | -60.53M 1,557.77% | 5.29M 108.75% | 191.67M 3,520.09% | -78.22M 140.81% | 40.85M 152.22% | -76.43M 287.09% | 2.89M 103.78% | |
cash at beginning of period | 3.38M - | 19.11M 465.97% | 132.51M 593.25% | 81.21M 38.71% | 85.37M 5.11% | 24.84M 70.90% | 30.13M 21.32% | 221.80M 636.08% | 143.58M 35.27% | 184.43M 28.45% | 108.00M 41.44% | |
cash at end of period | 19.11M - | 132.51M 593.25% | 81.21M 38.71% | 85.37M 5.11% | 24.84M 70.90% | 30.13M 21.32% | 221.80M 636.08% | 143.58M 35.27% | 184.43M 28.45% | 108.00M 41.44% | 110.89M 2.67% | |
operating cash flow | -19.03M - | -35.42M 86.08% | -65.71M 85.53% | -64.43M 1.95% | -23.94M 62.84% | -47.22M 97.27% | 173.03M 466.42% | -95.39M 155.13% | 171.22M 279.50% | -136.13M 179.50% | -153.89M 13.05% | |
capital expenditure | -296.88K - | -1.72M 478.47% | -1.97M 14.75% | -3.86M 95.89% | -7.92M 105.12% | -1.42M 82.05% | -12.00M 744.41% | -11.95M 0.41% | -23.57M 97.19% | -52.78M 123.94% | -176.74M 234.88% | |
free cash flow | -19.33M - | -37.13M 92.10% | -67.68M 82.26% | -68.29M 0.90% | -31.86M 53.35% | -48.64M 52.70% | 161.03M 431.04% | -107.34M 166.66% | 147.66M 237.56% | -188.91M 227.94% | -330.63M 75.02% |
All numbers in USD (except ratios and percentages)